BioInvent Extends Research Collaboration and License Agreement With Pfizer Inc.

LUND, Sweden, July 1, 2020 /PRNewswire/ — BioInvent International AB (“BioInvent” or the “Company”) (OMXS: BINV) today announces that it has further extended the research term under its cancer immuno …
(Orginal – Story lesen…)

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
668